Protease enzymes cut other proteins into pieces, but some can be blocked by inhibitors. One such inhibitor binds to the substrate rather than the enzyme, suggesting a new tactic for drug discovery.
Your institute does not have access to this article
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Kukar, T. L. et al. Nature 453, 925–929 (2008).
Flexner, C. N. Engl. J. Med. 338, 1281–1292 (1998).
Rich, J. B. et al. Neurology 45, 51–55 (1995).
Beher, D. et al. J. Biol. Chem. 279, 43419–43426 (2004).
Dong, D. L., Liu, R., Sherlock, R., Wigler, M. H. & Nestler, H. P. Chem. Biol. 6, 133–141 (1999).
Zhang, Z., Ly, T. & Kodadek, T. Chem. Biol. 8, 391–397 (2001).
Kodadek, T. Biopolym. Peptide Sci. 66, 134–140 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kodadek, T. Molecular cloaking devices. Nature 453, 861–862 (2008). https://doi.org/10.1038/453861a
Published:
Issue Date:
DOI: https://doi.org/10.1038/453861a
Further reading
-
Novel route to protease targeting
Nature Reviews Drug Discovery (2008)